DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

ATTAIN-J

Foundayo

Japan · mixed diabetes status · 72 weeks · n=238

Double-blind, placebo-controlled. Treatment-regimen analysis. Orforglipron was studied as capsules.

Mean body weight change at 72 weeks
  • Orforglipron 6 mg−5.9%
  • Orforglipron 12 mg−8.7%
  • Orforglipron 36 mg−7.9%
  • Placebo−0.6%

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.